126 related articles for article (PubMed ID: 15934917)
1. PKC eta as a therapeutic target in glioblastoma multiforme.
Martin PM; Hussaini IM
Expert Opin Ther Targets; 2005 Apr; 9(2):299-313. PubMed ID: 15934917
[TBL] [Abstract][Full Text] [Related]
2. PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways.
Aeder SE; Martin PM; Soh JW; Hussaini IM
Oncogene; 2004 Dec; 23(56):9062-9. PubMed ID: 15489897
[TBL] [Abstract][Full Text] [Related]
3. Atypical PKCι as target for glioblastoma therapy.
Lorimer IA
Curr Cancer Drug Targets; 2015; 15(2):136-44. PubMed ID: 25643257
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategies to target multiple kinases in glioblastoma.
Sathornsumetee S
Anticancer Agents Med Chem; 2011 Oct; 11(8):700-11. PubMed ID: 21707500
[TBL] [Abstract][Full Text] [Related]
5. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines.
Balça-Silva J; Matias D; do Carmo A; Girão H; Moura-Neto V; Sarmento-Ribeiro AB; Lopes MC
Biochim Biophys Acta; 2015 Apr; 1850(4):722-32. PubMed ID: 25554223
[TBL] [Abstract][Full Text] [Related]
7. ω-3 and ω-6 Fatty Acids Modulate Conventional and Atypical Protein Kinase C Activities in a Brain Fatty Acid Binding Protein Dependent Manner in Glioblastoma Multiforme.
Elsherbiny ME; Chen H; Emara M; Godbout R
Nutrients; 2018 Apr; 10(4):. PubMed ID: 29642372
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options.
Kalamatianos T; Denekou D; Stranjalis G; Papadimitriou E
Recent Pat Anticancer Drug Discov; 2018; 13(2):209-223. PubMed ID: 29336268
[TBL] [Abstract][Full Text] [Related]
9. Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta.
Martin PM; Aeder SE; Chrestensen CA; Sturgill TW; Hussaini IM
Oncogene; 2007 Jan; 26(3):407-14. PubMed ID: 16832347
[TBL] [Abstract][Full Text] [Related]
10. Receptor protein tyrosine phosphatase zeta as a therapeutic target for glioblastoma therapy.
Müller S; Lamszus K; Nikolich K; Westphal M
Expert Opin Ther Targets; 2004 Jun; 8(3):211-20. PubMed ID: 15161428
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C zeta isoform is critical for proliferation in human glioblastoma cell lines.
Donson AM; Banerjee A; Gamboni-Robertson F; Fleitz JM; Foreman NK
J Neurooncol; 2000 Apr; 47(2):109-15. PubMed ID: 10982151
[TBL] [Abstract][Full Text] [Related]
12. Targeting multiple kinases in glioblastoma multiforme.
Sathornsumetee S; Reardon DA
Expert Opin Investig Drugs; 2009 Mar; 18(3):277-92. PubMed ID: 19243279
[TBL] [Abstract][Full Text] [Related]
13. Current Perspectives on Therapies, Including Drug Delivery Systems, for Managing Glioblastoma Multiforme.
Bhaskaran M; Devegowda VG; Gupta VK; Shivachar A; Bhosale RR; Arunachalam M; Vaishnavi T
ACS Chem Neurosci; 2020 Oct; 11(19):2962-2977. PubMed ID: 32945654
[TBL] [Abstract][Full Text] [Related]
14. Targeting the AKT pathway in glioblastoma.
McDowell KA; Riggins GJ; Gallia GL
Curr Pharm Des; 2011; 17(23):2411-20. PubMed ID: 21827416
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation.
Rong X; Huang B; Qiu S; Li X; He L; Peng Y
Oncotarget; 2016 Dec; 7(51):83976-83986. PubMed ID: 27824617
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation.
Hussaini IM; Carpenter JE; Redpath GT; Sando JJ; Shaffrey ME; Vandenberg SR
Neuro Oncol; 2002 Jan; 4(1):9-21. PubMed ID: 11772428
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic therapies in glioblastoma multiforme.
McNamara MG; Mason WP
Expert Rev Anticancer Ther; 2012 May; 12(5):643-54. PubMed ID: 22594899
[TBL] [Abstract][Full Text] [Related]
18. Drug delivery approaches for the treatment of glioblastoma multiforme.
Fakhoury M
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
[TBL] [Abstract][Full Text] [Related]
19. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
20. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
